Surface Oncology OverviewSurface Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for SURF.
Quarterly EBIT
-$21.85M
↑ 11.27% YoY
As of Jun 30, 2023
Annual EBIT (TTM)
-$85.93M
↓ 40.95% YoY
Trailing 12 months ending Jun 30, 2023
Surface Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for SURF.
As of Jun 30, 2023
Trailing 12 months ending Jun 30, 2023